A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

Published Date: 17 Apr 2023

Canada: A recent clinical trial that was reported in JAMA: Surgery has demonstrated that using smartphone apps to track postoperative recovery can have positive effects.

Read Full News

Latest News

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Todays Updates

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Emerging ADC-Based Strategies in mNSCLC: Interpreting Clinical Evidence and Implications for Practice

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Bridging the Gap to CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Expert TheraTalk

Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

News, features, and commentary about cancer-related issues

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Liposomal Chemo Combination No Better Than Standard Induction in Pediatric AML

"This specific formulation of daunorubicin and cytarabine is not the right choice," experts said

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

Latest News

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

News All Time

Triplet Could Become a New Standard in Tough-to-Treat CLL

Adding a non-covalent BTK inhibitor improved progression-free survival

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening

News, features, and commentary about cancer-related issues

Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor

"I've taken bucketloads of this stuff," says Denise Sibley

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

A look at the "silent" impacts of cancer

More Data Back Teclistamab for Autoimmune Disease

Another case series shows most patients improved markedly after failing everything else

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false negatives

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

Health news and commentary gathered by MedPage Today staff

Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day

Editors "no longer have confidence in the integrity of the results"

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

Lymphoma-free survival exceeding 5 years in early recipients of the cellular therapy

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

And the fundamental question remains of whether doctors should be involved at all

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

News, features, and commentary about cancer-related issues

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

The presence of a beloved pet can ease the pain of terminally ill patients, says one doctor

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Also in TTHealthWatch: tranexamic acid in routine surgery

Study Homes In on Simpler Lung Cancer Screening Criteria

Researchers find benefits, trade-offs using various levels of smoking duration alone

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs

Why Are These Bones and Teeth Where They Shouldn't Be?

Discovery in 31-year-old woman made after she came to the ER with mild abdominal pain

Recommended News For You

Survival rates for incurable larynx cancer investigated for first time

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

Young adults who are obese are at risk for 17 different types of cancer in the future.

Healthy weight loss could lower your odds for cancer

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Recommended Articles For You

Case Learning from Acquired Platelet Function Disorders 

Strategic Applications in Hematology in Clinical Decision-Making 

Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology 

Progressive Perspectives in Oncology Across Clinical Settings 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

2.

Glioblastoma treatment breakthrough shows promise

3.

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

4.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

5.

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

1.

The Latest Research on Wiskott Aldrich Syndrome 

2.

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer

3.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

4.

Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy 

5.

Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot